Inhale and Biogen start inhaleable Avonex study

INHL and partner BGEN began dosing patients in a Phase I trial of inhaleable Avonex interferon beta-1a to treat multiple sclerosis (MS). BGEN markets its injectable Avonex to treat MS. ...